Changing pattern of epidemiology in intrahepatic cholangiocarcinoma

Hepatology

Volumn 60, Issue 3, 2014, Pages 1107-1108

  Njei, Basile ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EARLY DIAGNOSIS; HEALTH CARE UTILIZATION; HUMAN; LETTER; LIVER SURGERY; PRIORITY JOURNAL; UNITED STATES;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; INCIDENCE; MALE; UNITED STATES;

EID: 84906794854     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26958     Document Type: Letter

References (7)

1. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008;10: 77-82.
2. Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A (eds.). AJCC Cancer Staging Manual. New York: Springer; 2010.
3. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population based study of U.S. veterans. HEPATOLOGY 2009;49:116-123
4. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. HEPATOLOGY 2001;33:1353-1357.
5. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008;248:84-96.
6. Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 2006;45:856-867.
7. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19: 335-351.